Ishikawa M, Fernandez B, Kerbel R S
Department of Pathology, Mount Sinai Hospital Research Institute, Toronto, Ontario, Canada.
Cancer Res. 1988 Sep 1;48(17):4897-903.
The properties of a highly malignant human melanoma variant cell line which metastasizes in nude mice in a tissue-specific pattern are described. The variant, called 70-W, was isolated from the MeWo malignant melanoma by exposure of the latter to stepwise increasing concentrations of the toxic lectin, wheat germ agglutinin. After nine cycles of treatment a population of wheat germ agglutinin-resistant cells was obtained that manifested a 4-fold resistance to wheat germ agglutinin, a property which was found to be stable in culture for over 6 months in the absence of the lectin. Intravenous inoculation of 70-W cells into 4-6-week-old nude mice revealed remarkable differences in metastatic (organ colonization) behavior. Whereas the parent MeWo cells gave rise only to lung metastases, most of which were amelanotic, injection of the 70-W cells resulted in multiple skin (s.c.) and brain and, to a lesser extent, bone marrow, ovarian, mesenteric (gut-associated), muscle, and abdominal metastases all of which were highly melanotic. This is the first report of brain metastases of a human tumor in nude mice. They were found to be bilateral and confined to the deeper layers of the cerebral cortex. The unique malignant behavior of 70-W cells in nude mice should facilitate studies of host and tumor cell factors involved in human melanoma metastasis, melanogenesis, and development of new treatment strategies for disseminated human malignant melanoma.
本文描述了一种高恶性人类黑色素瘤变异细胞系的特性,该细胞系能以组织特异性模式在裸鼠体内发生转移。这种名为70-W的变异细胞系是通过将MeWo恶性黑色素瘤逐步暴露于浓度递增的有毒凝集素麦胚凝集素中而分离得到的。经过九个周期的处理后,获得了一群对麦胚凝集素具有抗性的细胞,它们对麦胚凝集素表现出4倍的抗性,并且发现在无凝集素的培养条件下,该特性在6个月以上保持稳定。将70-W细胞静脉注射到4至6周龄的裸鼠体内,结果显示其转移(器官定植)行为存在显著差异。亲本MeWo细胞仅引起肺转移,其中大多数为无黑色素转移灶;而注射70-W细胞则导致多处皮肤(皮下)、脑转移,以及程度较轻的骨髓、卵巢、肠系膜(与肠道相关)、肌肉和腹部转移,所有这些转移灶均高度黑色素化。这是关于人类肿瘤在裸鼠体内发生脑转移的首次报道。发现脑转移灶为双侧性,且局限于大脑皮质深层。70-W细胞在裸鼠体内独特的恶性行为应有助于研究参与人类黑色素瘤转移、黑色素生成的宿主和肿瘤细胞因子,以及开发针对播散性人类恶性黑色素瘤的新治疗策略。